A control study of Risperidone oral solution in treating chronic schizophrenia patients
Hui Huang
Abstract
Hui Huang
Abstract
Objective:To compare the efficacy and safety between Risperidone oral solution and Clozapine in the treatment of chronic schizophrenia patients.Methods:90 patients with chronic schizophrenia were randomly divided into study group(n=45) and control group(n=45),treated with Risperidone oral solution and Clozapine respectively for 8 weeks.The positive and negative syndomly scale(PANSS),Clinical Global Impression(CGI) was used to assess the therapeutic efficacy.The treatment emergent symptom scale(TESS) was used to assess side effect.Results: Risperidone oral solution was as effective as Clozapine for the treatment of chronic schizophrenia(P0.05).The marked improvement rate of the former was 70.5% and the later was 73.8%.The incidence rate of adverse effect was 50% in Risperidone oral solution group and that was 90.48% in Clozapine group.Significant differences were observed between them(P0.05).Conclusions: Risperidone oral solution is an effective and safe drug in the treatment of chronic schizophrenia.Its side effects were fewer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To compare the efficacy and safety between Risperidone oral solution and Clozapine in the treatment of chronic schizophrenia patients.Methods:90 patients with chronic schizophrenia were randomly divided into study group(n=45) and control group(n=45),treated with Risperidone oral solution and Clozapine respectively for 8 weeks.The positive and negative syndomly scale(PANSS),Clinical Global Impression(CGI) was used to assess the therapeutic efficacy.The treatment emergent symptom scale(TESS) was used to assess side effect.Results: Risperidone oral solution was as effective as Clozapine for the treatment of chronic schizophrenia(P0.05).The marked improvement rate of the former was 70.5% and the later was 73.8%.The incidence rate of adverse effect was 50% in Risperidone oral solution group and that was 90.48% in Clozapine group.Significant differences were observed between them(P0.05).Conclusions: Risperidone oral solution is an effective and safe drug in the treatment of chronic schizophrenia.Its side effects were fewer.
Key concepts: Risperidone, Schizophrenia (object-oriented programming), Clozapine, Clinical Global Impression, Adverse effect, Medicine, Internal medicine, Clinical efficacy